Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Markets & Finance

Merrill Starts Alcon at Strong Buy

Merrill Lynch initiated coverage of Alcon (ACL) with a near and long-term strong buy rating.

Analyst Steven Tighe says Alcon is the largest ophthalmic-specific company, a leader in the global eye care market with a 25% share in 2001. He says it is well managed and positioned to generate significant growth. Tighe sees annual top-line growth of 9%, EPS growth in the high-teens to low twenties in the next few years. He cites steady growth of existing products, strong growth of new products, leverage of global infrastructure, strong cash flow and deleveraging and tax rate improvements.

Tighe has a $40 12-month target on the stock, which assumes shares could trade at 25 times his $1.61 2003 EPS estimate.

blog comments powered by Disqus